Education
About Us
Working with TipRanks
Follow Us
Pediatrix Medical Group (MD)
NYSE:MD
Earnings Data
Report Date
Jul 31, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
0.43Last Year’s EPS
0.34Same Quarter Last Year
Based on 4 Analysts Ratings
Earnings Call Summary
Earnings Call Date:May 06, 2025
|% Change Since: 17.14%
|Next Earnings Date:Jul 31, 2025
Earnings Call Sentiment|Positive
The earnings call showcased strong first-quarter performance, with significant growth in same-unit revenues and effective cost management leading to an upward revision of the full-year outlook. However, challenges such as a decrease in consolidated revenue due to portfolio restructuring and economic uncertainties were noted. Overall, the highlights slightly outweighed the lowlights, indicating a cautiously optimistic outlook.Company Guidance
During the conference call, Pediatrix Medical Group provided updated guidance for fiscal year 2025, reflecting stronger-than-expected first-quarter performance. The company reported a same-unit revenue growth of over 6%, with NICU days increasing by 2%, and adjusted EBITDA exceeding expectations at just over $49 million. Consequently, Pediatrix raised its full-year adjusted EBITDA outlook from a range of $215 million to $235 million to a new range of $220 million to $240 million. The call highlighted the impact of strategic portfolio management in 2024 and emphasized a focus on strengthening relationships with hospital partners and enhancing recruitment and retention efforts. Despite a 7% decrease in consolidated revenue due to portfolio restructuring, same-unit pricing rose by 4.6%, driven by favorable payer mix shifts and robust RCM cash collections. The company maintained a conservative stance on future guidance amid ongoing economic and healthcare uncertainties, while noting improved cash collections and a stable DSO of under 48 days.Exceeding Expectations in Q1 2025
First quarter results exceeded expectations with a same-unit revenue growth of over 6% and adjusted EBITDA of just over $49 million, leading to an upward revision of the full-year 2025 adjusted EBITDA outlook to $220 million to $240 million.
Cost Management Success
Practice-level operating expenses reflect favorable impacts from cost management initiatives, with same-unit salary expense trends decelerating for the fourth consecutive quarter.
NICU and Hospital-Based Service Growth
NICU days increased by 2%, with strong volumes in hospital-based services contributing to overall growth.
Improved Cash Collections
Accounts receivable DSO improved by over four days year-over-year due to better cash collections at existing units.
Interest Income Boost
Interest income increased due to cash parked in attractive rate vehicles, contributing to other income.
MD Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
MD Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 06, 2025 | $12.95 | $14.48 | +11.81% |
Feb 20, 2025 | $14.11 | $17.23 | +22.11% |
Nov 01, 2024 | $12.32 | $15.21 | +23.46% |
Aug 06, 2024 | $7.62 | $8.97 | +17.72% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Pediatrix Medical Group (MD) report earnings?
Pediatrix Medical Group (MD) is schdueled to report earning on Jul 31, 2025, TBA Not Confirmed.
What is Pediatrix Medical Group (MD) earnings time?
Pediatrix Medical Group (MD) earnings time is at Jul 31, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is MD EPS forecast?
MD EPS forecast for the fiscal quarter 2025 (Q2) is 0.43.